FGFR2 and hepatocellular carcinoma: PTBP1 converts oncogenic FGFR2‐IIIb to pro‐carcinogenic FGFR2‐IIIc isoforms by modulating the selective splicing of FGFR2, which ultimately promotes hepatocellular carcinoma development [82].